CRV
NEUTRALCraven House Capital Plc: Notification of Major Shareholding Change
The investment company has received a notification of a change in major shareholding, with no clear impact on operations.
Craven House Capital
0.1250USD
0.00%
Market Cap
482.95k
Volume
67.47k
1418% of avg
P/E Ratio
EPS (TTM)
Beta
0.37
Day Range
0.0000p - 0.0000p
52 Week Range
0.0000p0.1250p0.4970p
0.1250p
CRV
BADCraven House Capital Reports Annual Loss Amid Strategic Portfolio Developments
The investment company reported an annual loss of $893,000 and negative equity, but highlighted strategic progress in its portfolio companies, including successful reverse takeovers and share distributions.
CRV
GOODCraven House Capital Boosts Portfolio with QuiaPeg Pharma Stake
Craven House Capital, an investment company, has boosted its portfolio with a stake in drug developer QuiaPeg Pharma.
CRV
NEUTRALMajor Shareholder Reduces Stake in Craven House Capital
Investment company sees shift in major shareholder
CRV
NEUTRALCraven House Capital Sees Shift in Major Shareholder
Financial services investment company sees shift in major shareholder